Chaz Goodwine

home / authors / chaz-goodwine

Chaz Goodwine is lead downstream scientist at AGC Biologics.

Articles

Станислав Чуб/Stock.adobe.com – a next generation convecdiff membrance was tested by AGC Biologics against a mAb created by the company.

Purification of Antibodies Using Novel Convecdiff Membranes Part 2: Robust Performance at Comparable Product Quality

Chaz Goodwine;Katrin Töppner;Patrick Adametz;Ricarda A. Busse;Volkmar Thom
February 2nd 2023

In part 2 of this article, results from the testing of a next generation convecdiff membrane are discussed.

Siarhei/Stock.adobe.com – Convecdiff membranes are a novel material for downstream purification that has shown favorable results for scale-up from lab bench to commercial-scale application.

Purification of Antibodies Using Novel Convecdiff Membranes Part 1: Providing High Binding Capacity at Short Residence Time and Low Pressure Drops

Katrin Töppner;Patrick Adametz;Chaz Goodwine;Ricarda A. Busse;Volkmar Thom
January 2nd 2023

The testing of new convecdiff membranes shows this material to be well suited for lab- and commercial-scale bind-and-elute applications.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: October 28th 2024 | Updated: November 25th 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 25th 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 25th 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 22nd 2024 | Updated: November 25th 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
© 2024 MJH Life Sciences

All rights reserved.